Harvoni

U.S. Senate Investigation Says Gilead puts Profits before Hepatitis C Patients

By Cheri Cheng - Dec 01, 2015 05:01 PM EST

A U.S. Senate investigation found that Gilead Sciences puts its profits ahead of patients who need life-saving hepatitis C drugs.

Fun Stuff

Editor's pick

Real Time Analytics